← Back to catalogue

Quidel Molecular Influenza A + B Assay

FDA 510(k)

Class II (US FDA 510(k))

510(k) K112172

by Quidel Corp.

Identifiers

510(k) Number
K112172 FDA 510(k)
FDA Product Code
OCC FDA 510(k)

Classification

Device Class
Class II FDA 510(k)
Legislation / Framework
21 CFR Part 866.3980 FDA 510(k)
Regulation Number
866.3980 FDA 510(k)
Advisory Committee
Microbiology FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)

The Quidel Molecular Influenza A + B Assay is a qualitative in vitro diagnostic test for the detection and differentiation of influenza A and influenza B viral RNA in nasal and nasopharyngeal swabs from patients with signs and symptoms of respiratory infection. It is a multiplex Real Time RT-PCR assay.

The assay is supplied for use in microbiology settings and is regulated under the product code OCC, with a regulation number of 866.3980. It has been cleared by the FDA under the traditional clearance type, with a decision code of SESE and a k number of K112172. The device is a Respiratory Virus Panel Nucleic Acid Assay System, classified as a class 2 device.

Frequently asked questions

What is the Quidel Molecular Influenza A + B Assay used for?

The Quidel Molecular Influenza A + B Assay is used for the detection and differentiation of influenza A and influenza B viral RNA in nasal and nasopharyngeal swabs from patients with signs and symptoms of respiratory infection.

How is the Quidel Molecular Influenza A + B Assay supplied?

The assay is supplied for use in microbiology settings.

What type of device is the Quidel Molecular Influenza A + B Assay?

The device is a Respiratory Virus Panel Nucleic Acid Assay System, classified as a class 2 device.

What is the regulatory classification of the Quidel Molecular Influenza A + B Assay?

The assay is regulated under the product code OCC, with a regulation number of 866.3980.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: SOLANA™ Influenza A+B Assay | QuidelOrtho, QUICKVUE™ Influenza A+B Test | QuidelOrtho, QUIDEL MOLECULAR INFLUENZA A + B ASSAY - Innolitics

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Quidel Corp.

Sources (1)

  • FDA 510(k) K112172 24 fields · synced Sep 21, 2026